Text Size

One-year results on the safety and efficacy of the InnFocus MicroShunt depending on placement and concentration of mitomycin C [Résultats à un an de l’efficacité et de l’innocuité du MicroShunt InnFocus selon l’emplacement et la concentration de MMC]

Riss I., Batlle J., Pinchuk L., Kato Y.P., Weber B.A., Parel J.-M.


  • 2015
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Pôle Ophtalmologique, Clinique Mutualiste, 46/54, avenue du Dr-Albert-Schweitzer, Pessac, 33600, France; Centro Laser, Santo Domingo, Calle Padre Fantino Falco 3, Santo Domingo, Dominica; InnFocus Inc., 12415 SW 136th Avenue #3, Miami, FL 33186, United States; Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller, 900 NW 17th Street, Miami, FL 33136, United States

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.


Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.


The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022